nektar therapeutics (NKTR:NASDAQ GS)
Michael A. Matthay M.D.
Member of Scientific Advisory Group and Member of Pulmonary Advisory Board, Nektar Therapeutics
|Age||Total Calculated Compensation||This person is connected to 55 board members in 2 different organizations across 2 different industries.|
See Board Relationships
Michael A. Matthay, M.D. is a Professor of Medicine and Anesthesiology, University of California, San Francisco and a Senior Associate at the Cardiovascular Research Institute. Dr. Matthay serves as a Member of Scientific Advisory Group of Nektar Therapeutics and a Member of its Pulmonary Advisory Board. He has been a Member of Scientific Advisory Board of Anthera Pharmaceuticals, Inc. since March 2007. He served as Chairman of the Respiration Section of the American ...
455 Mission Bay Boulevard SouthPhone: 415-482-5300
San Francisco, California 94158
Board Members Memberships*There is no Board Members Memberships data available.
Unknown/Other Education 1978
University of California-San Francisco
Unknown/Other Education 1976
University of Colorado–Boulder
University of Pennsylvania - School of Medicine
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Michael W. Aguiar||Chief Executive Officer, President and Director|
|Peter M. Hecht Ph.D.||Co-Founder, Chief Executive Officer and Director|
Ironwood Pharmaceuticals, Inc.
|James A. Schoeneck||Chief Executive Officer, President and Director|
|Peter S. Greenleaf||Chief Executive Officer and Director|
Sucampo Pharmaceuticals, Inc.
|Daniel J. Abdun-Nabi||Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee|
Emergent BioSolutions, Inc.
|$1.2M||Compensation as of Fiscal Year 2014.|